NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,168,602 | -0.7% | 4,856,000 | 0.0% | 0.59% | -5.5% |
| Q1 2023 | $4,199,900 | +34.9% | 4,856,000 | +38.7% | 0.62% | +32.8% |
| Q4 2022 | $3,113,250 | +0.5% | 3,500,000 | 0.0% | 0.47% | -15.2% |
| Q3 2022 | $3,098,000 | +1.8% | 3,500,000 | 0.0% | 0.55% | -9.4% |
| Q2 2022 | $3,043,000 | -44.3% | 3,500,000 | -41.7% | 0.61% | -50.2% |
| Q1 2022 | $5,460,000 | – | 6,000,000 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 46,391,000 | $42,604,000 | 1.32% |
| Lombard Odier Asset Management (Europe) Ltd | 171,980 | $15,871,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 80,367,000 | $73,232,000 | 0.68% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,419,000 | $5,736,000 | 0.39% |
| LINDEN ADVISORS LP | 63,485,000 | $58,560,000 | 0.36% |
| Ionic Capital Management LLC | 3,000,000 | $2,771,000 | 0.35% |
| SSI INVESTMENT MANAGEMENT LLC | 5,859,000 | $5,354,000 | 0.31% |
| Verition Fund Management LLC | 33,485,000 | $30,766,000 | 0.22% |
| Nicholas Investment Partners, LP | 3,550,000 | $3,244,000 | 0.20% |
| TFG Asset Management GP Ltd | 3,000,000 | $2,769,000 | 0.17% |